HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 123,650,000
- Total 13F shares
- 122,186,529
- Share change
- -1,312,594
- Total reported value
- $6,397,611,292
- Put/Call ratio
- 32%
- Price per share
- $52.36
- Number of holders
- 449
- Value change
- -$49,238,862
- Number of buys
- 230
- Number of sells
- 188
Quarterly Holders Quick Answers
What is CUSIP 40637H109?
CUSIP 40637H109 identifies HALO - HALOZYME THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 40637H109:
Top shareholders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
15%
|
18,241,548
|
$742,066,172 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
13,049,253
|
$530,843,613 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.2%
|
6,487,303
|
$263,903,486 | — | 31 Mar 2024 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
3.3%
|
4,117,227
|
$167,488,794 | — | 31 Mar 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
3.1%
|
3,791,230
|
$154,227,236 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
3%
|
3,666,324
|
$149,146,060 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.6%
|
3,240,497
|
$131,823,416 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
3,027,384
|
$123,171,534 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.4%
|
2,991,125
|
$121,679,000 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
2.1%
|
2,541,266
|
$103,378,701 | — | 31 Mar 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1.8%
|
2,196,877
|
$89,369,000 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.7%
|
2,088,410
|
$84,956,520 | — | 31 Mar 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.5%
|
1,858,841
|
$75,617,652 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.4%
|
1,791,904
|
$72,894,654 | — | 31 Mar 2024 | |
| THRIVENT FINANCIAL FOR LUTHERANS |
13F
|
Company |
1.4%
|
1,714,844
|
$69,760,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
1,697,152
|
$69,040,143 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.4%
|
1,688,229
|
$68,677,157 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.3%
|
1,667,479
|
$67,833,046 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.3%
|
1,651,610
|
$67,187,839 | — | 31 Mar 2024 | |
| Stephens Investment Management Group LLC |
13F
|
Company |
1.3%
|
1,546,666
|
$62,918,373 | — | 31 Mar 2024 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
1.2%
|
1,433,612
|
$58,319,336 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,355,442
|
$55,139,397 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
1,298,844
|
$52,838,000 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1%
|
1,240,476
|
$50,462,564 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.98%
|
1,214,185
|
$49,393,063 | — | 31 Mar 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.97%
|
1,194,464
|
$48,590,795 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.74%
|
917,759
|
$37,334,436 | — | 31 Mar 2024 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.67%
|
828,669
|
$33,710,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.66%
|
821,386
|
$33,413,982 | — | 31 Mar 2024 | |
| Granite Investment Partners, LLC |
13F
|
Company |
0.66%
|
811,458
|
$33,010,111 | — | 31 Mar 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.65%
|
805,975
|
$32,786,000 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.61%
|
748,722
|
$30,458,012 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.56%
|
696,127
|
$28,318,463 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.52%
|
637,276
|
$25,924,403 | — | 31 Mar 2024 | |
| Boston Partners |
13F
|
Company |
0.51%
|
630,368
|
$25,500,232 | — | 31 Mar 2024 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.49%
|
603,137
|
$24,535,613 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.46%
|
570,757
|
$23,218,394 | — | 31 Mar 2024 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.46%
|
568,361
|
$23,120,908 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.43%
|
531,125
|
$21,603,661 | — | 31 Mar 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.42%
|
519,430
|
$21,177,162 | — | 31 Mar 2024 | |
| 2Xideas AG |
13F
|
Company |
0.42%
|
515,462
|
$20,968,994 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
513,096
|
$20,872,745 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.41%
|
505,101
|
$20,547,509 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.4%
|
490,665
|
$19,960,000 | — | 31 Mar 2024 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.39%
|
485,234
|
$19,739,319 | — | 31 Mar 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.37%
|
461,800
|
$18,786,000 | — | 31 Mar 2024 | |
| MIZUHO MARKETS AMERICAS LLC |
13F
|
Company |
0.37%
|
456,636
|
$18,575,952 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.35%
|
431,828
|
$17,566,735 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.35%
|
431,380
|
$17,549,000 | — | 31 Mar 2024 | |
| CONGRESS ASSET MANAGEMENT CO |
13F
|
Company |
0.33%
|
407,867
|
$16,592,030 | — | 31 Mar 2024 |
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2024
As of 30 Jun 2024,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
449 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,186,529 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, SNYDER CAPITAL MANAGEMENT L P, Artisan Partners Limited Partnership, ALLIANCEBERNSTEIN L.P., MACQUARIE GROUP LTD, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and TD Asset Management Inc.
This page lists
450
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
409
Q2 2024 holders
449
Holder diff
40
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.